Pharmaceutical Industry

Page 24 of 100

Gloved hand holding pills in front of Sanofi corporate logo
Health

Sanofi agrees to partnership with A.I.-based drug discovery company Exscientia worth up to $5.2 billion

By
January 7, 2022
World leaders should acknowledge that IP protections facilitate vaccine access
Commentary

World leaders should acknowledge that IP protections facilitate vaccine access

By
December 24, 2021
AstraZeneca finds its COVID booster delivers adequate protection against Omicron
Health

AstraZeneca finds its COVID booster delivers adequate protection against Omicron

By Suzi Ring and Bloomberg
December 23, 2021
Del-Kar Pharmacy owner Edwin Muldrow
Health

One Chicago pharmacy avoids creating another drugstore desert by tapping into its deep roots

By Markian Hawryluk and Kaiser Health News
December 22, 2021
EU bulks up its arsenal against Omicron with approval of Novavax vaccine. Investors dump shares
Health

EU bulks up its arsenal against Omicron with approval of Novavax vaccine. Investors dump shares

By
December 20, 2021
Biogen headquarters
Health

Biogen slashes cost of Alzheimer’s drug by 50% six months after FDA approval

By Timothy Annett and Bloomberg
December 20, 2021
‘Pharma Bro’ drugmaker will pay up to $40 million to settle case over jacking up medicine price by 4,000%
Health

‘Pharma Bro’ drugmaker will pay up to $40 million to settle case over jacking up medicine price by 4,000%

By
December 8, 2021
Insulin’s deadly cost: Ultrahigh prices in the U.S. mean many diabetics can’t afford the medication they need to survive
Magazine

Insulin’s deadly cost: Ultrahigh prices in the U.S. mean many diabetics can’t afford the medication they need to survive

By
December 6, 2021
A health worker speaks with a patient in the reception area of a Testaro Covid-19 testing site in the Goodwood district of Cape Town, South Africa,
Health

Omicron vaccine to begin clinical trial in South Africa

By
December 6, 2021
If we want the pandemic to end, CEOs need to do what governments won’t—including getting tougher and smarter about vaccines
Commentary

If we want the pandemic to end, CEOs need to do what governments won’t—including getting tougher and smarter about vaccines

By Mark Dybul and Serhat Gümrükçü
December 1, 2021
The most important meeting yet for global pandemic response—and drugmakers
Commentary

The most important meeting yet for global pandemic response—and drugmakers

By Nicole Hassoun and Kaushik Basu
November 29, 2021
To avoid the superbug pandemic, we must fix the business model for new antibiotics
Commentary

To avoid the superbug pandemic, we must fix the business model for new antibiotics

By Michelle McMurry-Heath and Henry Skinner
November 25, 2021
DeepMind and now Isomorphic Laboratories CEO Demis Hassabis
Tech

DeepMind spins out new Alphabet company focused on drug discovery

By
November 4, 2021
Riding high off vaccine wins, Pfizer CEO Albert Bourla delves into his strategy for the year ahead
Features

Riding high off vaccine wins, Pfizer CEO Albert Bourla delves into his strategy for the year ahead

By
October 30, 2021
COVID-19 experimental antiviral drug MOLNUPIRAVIR, two white pills with letters engraved on side, potential experimental WHO Coronavirus cure, pandemic outbreak crisis, isolated on blue background
Health

Merck says poorer countries can produce its new COVID pill without paying royalties

By
October 27, 2021

Most Popular